Prot # 547-SSE-301: Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sage-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepicus

Project: Research project

Project Details

StatusFinished
Effective start/end date10/7/1510/7/18

Funding

  • MS Clinical Services, LLC (547-SSE-301)
  • Sage Therapeutics, Inc. (547-SSE-301)